PARP-1 inhibitors (Angion Biomedica)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePARP-1 inhibitors (Angion Biomedica)
Drug Alias NameANG-3038ANG-2684ANG-3186
ClassificationSmall molecules
Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 inhibitorsNeuroprotectants
TargetsPoly (ADP-Ribose) polymerase 1
Therapy Area/IndicationsStrokePancreatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElicio Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElicio Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsStrokePancreatitis

Other Information

ATC CodeN/A
Related LinksN/A